Arch Biopartners Inc.
Arch Biopartners Inc.
Indice CSE:
Devise:
Arch Biopartners is a portfolio based biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies. The Company’s lead technology, MetaMx, targets brain tumor initiating cells for the purpose of developing new imaging, diagnostic and therapeutic treatments for malignant glioma.
Arch Biopartners Inc. (ACH)
SEDAR Information
Information d'entreprise
Addresse
27 St. Clair Ave East P.O. Box 305
Toronto, ON M4T 2M5
CanadaTéléphone
1-647-428-7031Courriel
[email protected]URL
http://www.archbiopartners.comDate d’inscription à la cote
Vendredi, mai 7, 2010Relations avec les investisseurs
n/aVérificateur
EXG Chartered AccountantsCapitalisation
Capitalisation:
50975179Réservé à l'émission:
2024500Communiqués de presse
Bulletins
05/05/2010
2010-0502 - New Listing - Arch Biopartners Inc. (ACH)
May 5, 2010
The common shares of Arch Biopartners Inc. have been approved for listing on CNSX. The Company has 47,360,179 common shares outstanding with a public float of approximately 27.7 million shares.
